Clinical trial
A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis…
NCT00397683 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00397683 |
|---|---|
| Title | A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis (MK-0822-011) |
| Official title | Proprietary Information - Exploratory (Non-Confirmatory) Trial |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | MK0822 |
| Enrollment | 2 |
| Start date | Oct 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Nov 9, 2006 |
| Last update posted | Nov 2, 2015 |
| Countries | Chile, Colombia, Mexico, Poland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: